U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 30

1.

Thalidomide

A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.

2.

Angiogenesis Inhibitors

Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.

Year introduced: 2004(2000)

3.

Teratogens

An agent that causes the production of physical defects in the developing embryo.

Year introduced: 1975

4.

Leprostatic Agents

Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions.

Year introduced: 1975

5.

Immunosuppressive Agents

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Year introduced: 1966(1964)

6.

Isoindoles

Benzopyrroles with the nitrogen at the number two carbon, in contrast to INDOLES which have the nitrogen adjacent to the six-membered ring.

Year introduced: 2008

7.

Piperidones

A family of saturated heterocyclic organic compounds which contain one nitrogen atom and a carbonyl group in the ring structure.

Year introduced: 1991(1971)

8.

Piperidines

A family of hexahydropyridines.

Year introduced: AZACYCLONOL was heading 1963-1984

9.

Phthalimides

The imide of phthalic acids.

Year introduced: 1975

10.

Phthalic Acids

A group of compounds that has the general structure of a dicarboxylic acid-substituted benzene ring. The ortho-isomer is used in dye manufacture. (Dorland, 28th ed)

Year introduced: 1975

11.

Organic Chemicals

A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.

Year introduced: 1998

12.

Heterocyclic Compounds, 2-Ring

A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category.

Year introduced: 1998

13.

Heterocyclic Compounds, 1-Ring

Organic compounds that contain a ring structure made up of carbon and one or more additional elements such as nitrogen and oxygen.

Year introduced: 1998

14.

Heterocyclic Compounds

Cyclic compounds that include atoms other than carbon in their ring structure.

15.

Carboxylic Acids

Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.

Year introduced: 1973(1971)

16.

Acids, Carbocyclic

Carboxylic acids that have a homocyclic ring structure in which all the ring atoms are carbon.

Year introduced: 1998

17.

Heterocyclic Compounds, Fused-Ring

Multiple ring heterocyclic compounds containing two or more rings that share two atoms and one bond in common.

Year introduced: 2017

18.

Therapeutic Uses

Uses of chemicals which affect the course of conditions, diseases, syndromes or pathology to benefit the health of an individual.

Year introduced: 2004

19.

Physiological Effects of Drugs

Activities which affect organs and systemic functions without regard to a particular disease.

Year introduced: 2004

20.

Angiogenesis Modulating Agents

Agents that modulate the PHYSIOLOGIC ANGIOGENESIS process. This is accomplished by endogenous ANGIOGENIC PROTEINS and a variety of other chemicals and pharmaceutical agents.

Year introduced: 2004

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Loading ...